Search - tctmd.com

Displaying 1 - 20 of 972

Sort: Relevancy | Date

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

Presentation TCT 2016

Syncardia: The Irreplaceable Role of the Total Artificial Heart

Presenter: Daniel Burkhoff, Yoshifumi Naka, Keyur Bharat Shah

November 01, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care

Presenter: Daniel Burkhoff, Yoshifumi Naka, Nir Uriel

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

Jarvik: Has the Problem of Driveline Infections Been Solved?

Presenter: Daniel Burkhoff, Yoshifumi Naka

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

Heart Mate III: Has the Problem of Thrombus Been Solved?

Presenter: Daniel Burkhoff, Yoshifumi Naka, James W Long

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

HVAD & MVAD

Presenter: Daniel Burkhoff, Yoshifumi Naka, Palak Shah

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients

Presenter: Daniel Burkhoff, Yoshifumi Naka, Nir Uriel

November 01, 2016

Presentation TCT 2016

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

Presenter: Daniel Burkhoff, Yoshifumi Naka, James W Long

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

Interventional Imaging of the Tricuspid Valve

Presenter: Joachim Schofer, Alec S. Vahanian, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Think Twice: BRS First

Presenter: George D. Dangas, Fabio Felice Tarantino, Francesco Saia

November 01, 2016

Advertisement

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Syncardia: The Irreplaceable Role of the Total Artificial Heart

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Jarvik: Has the Problem of Driveline Infections Been Solved?

What Should Be the Next Series of Clinical Trials in PFO Closure?

Heart Mate III: Has the Problem of Thrombus Been Solved?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

HVAD & MVAD

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

Case Conclusion: How Did I Treat?

Interventional Imaging of the Tricuspid Valve

Case Conclusion: How Did We Treat Our Patient?

Building a Successful PFO Closure Program

Think Twice: BRS First

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content